Medicamen Biotech has informed that the Board of Directors of the Company, at their meeting held today, September 12, 2022 at 1506, Chiranjiv Tower, 43, Nehru Place, New Delhi-110019h has considered and approved the following businesses: Allotment of 4,34,500 Equity Share for cash at an issue price of Rs 709 per Equity Share by way of preferential allotment; Allotment of 63,500 Fully Convertible Warrants ('Warrants') each carrying a right to subscribe to one Equity Share per Warrant, for cash at an issue price of Rs 709 per warrant by way of preferential allotment.
The above information is a part of company’s filings submitted to BSE.
